lh-theme

primary-extra-dark

lh-content-width

xl

lh-padding-top

sm

lh-padding-bottom

sm

Xdemvy Prior Authorization Criteria - Medicare Part D

lh-theme

primary-extra-dark

lh-content-width

md

lh-padding-top

none

lh-padding-bottom

md

Medicare Utilization Management Policy

lh-theme

primary-extra-dark

lh-content-width

md

lh-padding-top

none

lh-padding-bottom

md

Version Date: January 1, 2025

lh-theme

primary-extra-dark

lh-content-width

md

lh-padding-top

none

lh-padding-bottom

md

lh-spacing

extra-tight

Prior authorization criteria for approval

Xdemvy will be approved when the following is met:

1. The patient has an FDA labeled indication for the requested medication

Length of Approval: 6 weeks

lh-theme

neutral-light

lh-content-width

md

lh-padding-top

xl

lh-padding-bottom

xl